Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (r/m HNSCC). Sun L, Cohen RB, Dimitrios Colevas A. Oral Oncol 2024;158:106997.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sun L, Cohen RB, Dimitrios Colevas A. Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (r/m HNSCC). Oral Oncol 2024;158:106997.
PMID: 39159526